AU707675B2 - Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) - Google Patents

Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) Download PDF

Info

Publication number
AU707675B2
AU707675B2 AU21240/97A AU2124097A AU707675B2 AU 707675 B2 AU707675 B2 AU 707675B2 AU 21240/97 A AU21240/97 A AU 21240/97A AU 2124097 A AU2124097 A AU 2124097A AU 707675 B2 AU707675 B2 AU 707675B2
Authority
AU
Australia
Prior art keywords
compound
formulation
formula
desmoid
fibromatoses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU21240/97A
Other languages
English (en)
Other versions
AU2124097A (en
Inventor
Maria L. Brandi
Francesco Tonelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603148.9A external-priority patent/GB9603148D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2124097A publication Critical patent/AU2124097A/en
Application granted granted Critical
Publication of AU707675B2 publication Critical patent/AU707675B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
AU21240/97A 1996-01-29 1997-01-27 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) Ceased AU707675B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1077396P 1996-01-29 1996-01-29
US60/010773 1996-01-29
GB9603148 1996-02-15
GBGB9603148.9A GB9603148D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
PCT/US1997/002287 WO1997026878A1 (en) 1996-01-29 1997-01-27 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)

Publications (2)

Publication Number Publication Date
AU2124097A AU2124097A (en) 1997-08-20
AU707675B2 true AU707675B2 (en) 1999-07-15

Family

ID=26308707

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21240/97A Ceased AU707675B2 (en) 1996-01-29 1997-01-27 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)

Country Status (11)

Country Link
EP (1) EP0907361A4 (xx)
JP (1) JP2000503995A (xx)
KR (1) KR19990082055A (xx)
CN (1) CN1209746A (xx)
AU (1) AU707675B2 (xx)
CZ (1) CZ235398A3 (xx)
EA (1) EA199800678A1 (xx)
IL (1) IL125523A0 (xx)
NO (1) NO983452L (xx)
PL (1) PL328127A1 (xx)
WO (1) WO1997026878A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2135195C1 (ru) * 1998-12-17 1999-08-27 Овсюк Валерий Григорьевич Способ получения материала, содержащего клетки предстательной железы, материал, содержащий клетки предстательной железы, и способы лечения фиброматоза матки, хронического простатита и нарушений мужской половой функции методом трансплантации
AU781168B2 (en) 2001-01-26 2005-05-12 Pfizer Products Inc. Method of treating certain cancers using an estrogen agonist/antagonist

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
US5457116A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods of inhibiting uterine fibrosis
CA2118096A1 (en) * 1993-10-15 1995-04-16 Srinivasan Chandrasekhar Methods for treating resistant neoplasms
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
NO983452D0 (no) 1998-07-27
KR19990082055A (ko) 1999-11-15
EP0907361A4 (en) 2002-05-02
PL328127A1 (en) 1999-01-18
WO1997026878A1 (en) 1997-07-31
CN1209746A (zh) 1999-03-03
EA199800678A1 (ru) 1999-02-25
NO983452L (no) 1998-07-27
JP2000503995A (ja) 2000-04-04
AU2124097A (en) 1997-08-20
CZ235398A3 (cs) 1999-02-17
IL125523A0 (en) 1999-03-12
EP0907361A1 (en) 1999-04-14

Similar Documents

Publication Publication Date Title
AU699948B2 (en) Methods of inhibiting atrophy of the skin and vagina
AU691844B2 (en) Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome
AU692491B2 (en) Methods of inhibiting CNS problems in post-menopausal women
AU701701B2 (en) Methods of inhibiting breast disorders
US5451590A (en) Methods of inhibiting sexual precocity
US5843974A (en) Methods of inhibiting melanoma using Benzothiophenes as cytotoxic agents per se
US5670523A (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
AU707675B2 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
AU690162B2 (en) Methods of inhibiting hirsutism and alopecia in women
CA2244247A1 (en) Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors)
CA2170480A1 (en) Methods of inhibiting estrogen positive tumors of the brain or cns
AU707892B2 (en) Methods of inhibiting colon tumors
CA2244112A1 (en) Methods of inhibiting colon tumors

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired